# Neuvivo jobs and careers

> 0 open roles at Neuvivo as of October 24, 2026. Source: https://www.thejobsmap.com/company/neuvivo

Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We have developed a patented macrophage-targeted technology, NP001, that addresses chronic inflammation, a key factor in the progressive loss of motor function in ALS. NP001 has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unmet medical need. We are working to move this compound toward approval and delivering an effective and safe new treatment for ALS.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Founded | 2020 |
| Employees | 1 to 10 |
| Total funding | $11M |
| Industries | Biotechnology, Health Care, Therapeutics |
| Website | https://neuvivo.com |

## Leadership

- Vern Norviel, Founder And Board Member

## Common questions

### Is Neuvivo hiring right now?

Neuvivo has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Neuvivo's careers site.

### Who leads Neuvivo?

Vern Norviel, Founder And Board Member, is at the top of Neuvivo's org chart.

### How do I apply for a job at Neuvivo?

Pick a role on Neuvivo's TheJobsMap page and select Apply. Every listing links to the original posting on Neuvivo's own careers site, so you apply directly with the employer.